These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23119051)

  • 1. A phage display selected 7-mer peptide inhibitor of the Tannerella forsythia metalloprotease-like enzyme Karilysin can be truncated to Ser-Trp-Phe-Pro.
    Skottrup PD; Sørensen G; Ksiazek M; Potempa J; Riise E
    PLoS One; 2012; 7(10):e48537. PubMed ID: 23119051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the catalytic domain of the Tannerella forsythia matrix metallopeptidase karilysin in complex with a tetrapeptidic inhibitor.
    Guevara T; Ksiazek M; Skottrup PD; Cerdà-Costa N; Trillo-Muyo S; de Diego I; Riise E; Potempa J; Gomis-Rüth FX
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 May; 69(Pt 5):472-6. PubMed ID: 23695557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phage display selection of human single domain antibodies towards karilysin, a metalloproteinase and secreted virulence factor from Tannerella forsythia.
    Skottrup PD; Książek M; Potempa J
    J Immunol Methods; 2023 May; 516():113458. PubMed ID: 36921710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure of the catalytic domain of Tannerella forsythia karilysin reveals it is a bacterial xenologue of animal matrix metalloproteinases.
    Cerdà-Costa N; Guevara T; Karim AY; Ksiazek M; Nguyen KA; Arolas JL; Potempa J; Gomis-Rüth FX
    Mol Microbiol; 2011 Jan; 79(1):119-32. PubMed ID: 21166898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel matrix metalloprotease-like enzyme (karilysin) of the periodontal pathogen Tannerella forsythia ATCC 43037.
    Karim AY; Kulczycka M; Kantyka T; Dubin G; Jabaiah A; Daugherty PS; Thogersen IB; Enghild JJ; Nguyen KA; Potempa J
    Biol Chem; 2010 Jan; 391(1):105-17. PubMed ID: 19919176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pathogenic trace of Tannerella forsythia - shedding of soluble fully active tumor necrosis factor α from the macrophage surface by karilysin.
    Bryzek D; Ksiazek M; Bielecka E; Karim AY; Potempa B; Staniec D; Koziel J; Potempa J
    Mol Oral Microbiol; 2014 Dec; 29(6):294-306. PubMed ID: 25175980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An IgY-based immunoassay to evaluate the biomarker potential of the Tannerella forsythia virulence factor karilysin in human saliva.
    Skottrup PD; López R; Ksiazek M; Højrup P; Baelum V; Potempa J; Kaczmarek JZ
    J Immunol Methods; 2019 Jun; 469():26-32. PubMed ID: 30880264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system.
    Jusko M; Potempa J; Karim AY; Ksiazek M; Riesbeck K; Garred P; Eick S; Blom AM
    J Immunol; 2012 Mar; 188(5):2338-49. PubMed ID: 22287711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic inactivation of LL-37 by karilysin, a novel virulence mechanism of Tannerella forsythia.
    Koziel J; Karim AY; Przybyszewska K; Ksiazek M; Rapala-Kozik M; Nguyen KA; Potempa J
    J Innate Immun; 2010; 2(3):288-93. PubMed ID: 20375548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Metalloproteinase Mirolysin of Tannerella forsythia Inhibits All Pathways of the Complement System.
    Jusko M; Potempa J; Mizgalska D; Bielecka E; Ksiazek M; Riesbeck K; Garred P; Eick S; Blom AM
    J Immunol; 2015 Sep; 195(5):2231-40. PubMed ID: 26209620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mechanism of latency in matrix metalloproteinases.
    López-Pelegrín M; Ksiazek M; Karim AY; Guevara T; Arolas JL; Potempa J; Gomis-Rüth FX
    J Biol Chem; 2015 Feb; 290(8):4728-4740. PubMed ID: 25555916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New inhibitors of Helicobacter pylori urease holoenzyme selected from phage-displayed peptide libraries.
    Houimel M; Mach JP; Corthésy-Theulaz I; Corthésy B; Fisch I
    Eur J Biochem; 1999 Jun; 262(3):774-80. PubMed ID: 10411639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel exosite on coagulation factor VIIa and its molecular interactions with a new class of peptide inhibitors.
    Roberge M; Santell L; Dennis MS; Eigenbrot C; Dwyer MA; Lazarus RA
    Biochemistry; 2001 Aug; 40(32):9522-31. PubMed ID: 11583151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide analogues of the VanS catalytic center inhibit VanR binding to its cognate promoter.
    Ulijasz AT; Kay BK; Weisblum B
    Biochemistry; 2000 Sep; 39(37):11417-24. PubMed ID: 10985787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Miropin, a novel bacterial serpin from the periodontopathogen Tannerella forsythia, inhibits a broad range of proteases by using different peptide bonds within the reactive center loop.
    Ksiazek M; Mizgalska D; Enghild JJ; Scavenius C; Thogersen IB; Potempa J
    J Biol Chem; 2015 Jan; 290(1):658-70. PubMed ID: 25389290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane protein topology determination by proteolysis of maltose binding protein fusions.
    Miller KW; Konen PL; Olson J; Ratanavanich KM
    Anal Biochem; 1993 Nov; 215(1):118-28. PubMed ID: 8297003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptides as inhibitors of the first phosphorylation step of the Streptomyces coelicolor phosphoenolpyruvate: sugar phosphotransferase system.
    Doménech R; Martínez-Rodríguez S; Velázquez-Campoy A; Neira JL
    Biochemistry; 2012 Sep; 51(37):7393-402. PubMed ID: 22909257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Landscape phages and their fusion proteins targeted to breast cancer cells.
    Fagbohun OA; Bedi D; Grabchenko NI; Deinnocentes PA; Bird RC; Petrenko VA
    Protein Eng Des Sel; 2012 Jun; 25(6):271-83. PubMed ID: 22490956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phage display-derived inhibitor of the essential cell wall biosynthesis enzyme MurF.
    Paradis-Bleau C; Lloyd A; Sanschagrin F; Clarke T; Blewett A; Bugg TD; Levesque RC
    BMC Biochem; 2008 Dec; 9():33. PubMed ID: 19099588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble mimics of the cytoplasmic face of the human V1-vascular vasopressin receptor bind arrestin2 and calmodulin.
    Wu N; Macion-Dazard R; Nithianantham S; Xu Z; Hanson SM; Vishnivetskiy SA; Gurevich VV; Thibonnier M; Shoham M
    Mol Pharmacol; 2006 Jul; 70(1):249-58. PubMed ID: 16574744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.